NCT04612374View on ClinicalTrials.gov

Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

August 4, 2022

Study Completion Date

August 4, 2022

Conditions
Misophonia
Interventions
BEHAVIORAL

Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Please see arm/group descriptions

BEHAVIORAL

Revised Unified Protocol for Transdiagnostic Treatment of Emotional Disorders

Please see arm/group descriptions

Trial Locations (1)

27701

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER